Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Ropinirole in Gilles de la Tourette Syndrome
Neurol 62:1626-1627, Anea,M.H.,et al, 2004
See this aricle in Pubmed

Article Abstract
The effects of treatment with ropinirole (0.25 to 0.5 mg bid) were examined using an open-label design for 8 weeks in 15 subjects with Gilles de la Tourette syndrome (GdlT). All patients completed the study and most showed an improvement in their tics during treatment. Low-dose ropinirole may improve the motor features in GdlT, but further controlled studies are necessary.
 
Related Tags
(click to filter results - removes previous filter)

dopamine agonist
Gilles de la Tourette syndrome
ropinirole
treatment of neurologic disorder

Click Here to return To Results